Company Description
Pharmaceutical giant Bristol-Myers Squibb (BMS) makes big bucks on matters of the heart. The company's blockbuster cardiovascular line-up includes...
Key Bristol-Myers Squibb Financials
| Company Type | Public - NYSE: BMY Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $19,348.0 |
| 2007 Employees | 42,000 |
More Bristol-Myers Squibb Financials (11 pages)
Rankings
- #125 in FORTUNE 500
- S&P 500
- #138 in FT Global 500
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Bristol-Myers Squibb's competition across multiple industries
Top Bristol-Myers Squibb Competitors
Sponsored Links
The Business Directory
Bristol-Myers Squibb Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | James M. (Jim) Cornelius | Network | E-mail |
| EVP and COO | Lamberto Andreotti | Network | E-mail |
| SVP Corprate and Business Communications, and Chief Communications Officer; CEO, BMS Foundation | Robert T. Zito | Network | E-mail |
More Bristol-Myers Squibb Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Bristol-Myers Squibb News
- Bloomsbury Publishing PLC (BLPU.L) Weekly Earnings Information [Nelson Information - Weekly Non-Domestic] (17 May 2008 11:35:00 EDT)
- Bristol-Myers Squibb Co(GAAP) (BMY.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 02:29:00 EDT)
- Bristol-Myers Squibb C(Alt EPS) (BMY.AL) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 01:16:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.